$CTVA · Corteva, Inc.

Corteva's board approved the separation of its seed operating segment into Vylor Inc., an independent publicly traded company. The spin-off will be executed via a pro rata dividend of Vylor common stock to Corteva stockholders of record as of September 24, 2026, with distribution expected before market open on October 1, 2026. Each Corteva stockholder receives one Vylor share per Corteva share held, with cash in lieu of fractional shares. The transaction is intended to be tax-free for U.S. federal income tax purposes.

Extended-hours trading shows CTVA at $82.30, down 0.31% from the regular close of $82.56 — a muted initial reaction to the long-telegraphed spin-off approval. Markets were closed at filing time, so the first full regular-session reaction is still pending.

The formal board approval and distribution timeline transform Corteva's long-telegraphed seed spin-off from plan to execution, creating two pure-play public companies with distinct investment profiles

Corteva joins a wave of agribusiness separations (e.g., FMC, Bayer restructuring) as pure-play seed/genetics companies command premium valuations. Vylor's standalone debut lets the market separately price Corteva's crop protection and digital assets versus its seed portfolio.

The spin-off may not achieve its objectives; could disrupt customer, supplier, and employee relationships; may divert management attention; and could trigger unexpected costs or litigation. The distribution remains subject to satisfaction or waiver of customary conditions.